Which company makes HIV medicine?
Gilead is the drug manufacturer most specialized in developing drugs for the treatment of HIV/AIDS. HIV is a virus that attacks the immune system, leading to an increased risk of infections and can lead to death. HIV/AIDS first appeared in global populations in the 1980s.
What is the best HIV medication on the market?
FDA-Approved HIV Medicines
| Drug Class | Generic Name (Other names and acronyms) | Brand Name |
|---|---|---|
| NRTIs block reverse transcriptase, an enzyme HIV needs to make copies of itself. | emtricitabine (FTC) | Emtriva |
| lamivudine (3TC) | Epivir | |
| tenofovir disoproxil fumarate (tenofovir DF, TDF) | Viread | |
| zidovudine (azidothymidine, AZT, ZDV) | Retrovir |
Which company makes HIV drugs in India?
In 1991, Rama Rao, the research head of an Indian government laboratory, told Hamied that he had developed a chemical synthesis of AZT, or azidothymidine, and wanted Cipla to manufacture it. It was the only drug that postponed the onset of AIDS.
What is the safest HIV drug?
“Findings from the VESTED study suggest that a drug regimen containing dolutegravir provides the safest, most effective HIV treatment available during this critical time for women and their infants,” said Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, sponsor of the trial.
What does Gilead Sciences make?
Gilead Sciences
| Type | Public |
|---|---|
| Products | AmBisome Atripla Biktarvy Complera Cayston Descovy Emtriva Epclusa Genvoya Harvoni Hepsera Letairis Lexiscan Macugen Odefsey Ranexa Sovaldi Stribild Tamiflu Truvada Tybost Veklury Vemlidy Viread Vosevi Yescarta Zydelig |
| Revenue | US$22.45 billion (2019) |
| Operating income | US$4.29 billion (2019) |
Who is Descovy indicated for?
Descovy for PrEP™ is indicated to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are HIV-negative and at-risk for sexually acquired HIV, excluding individuals at-risk from receptive vaginal sex.
Who is founder of Cipla?
Khwaja Abdul Hamied
Cipla/Founders
Yusuf Hamied is the nonexecutive chairman of $2.6 billion (revenue) generics maker Cipla. The company was founded in 1935 by his father Khwaja Abdul Hamied, a disciple of Mahatma Gandhi.